2-amino-3-benzoylbenzeneacetamide,
nepafenac,
Nevanac,
Nepafenac,
78281-72-8,
Nevanac,
2-Amino-3-benzoylbenzeneacetamide,
2-(2-Amino-3-benzoylphenyl)acetamide,
Ilevro,
AL 6515,
AHR 9434,
AHR-9434,
AL-6515,
Amfenac amide,
UNII-0J9L7J6V8C,
Benzeneacetamide, 2-amino-3-benzoyl-,
CHEBI:75922,
0J9L7J6V8C,
2-amino-3-benzoyl-benzeneacetamide,
MFCD08067732,
2-(2-amino-3-benzoyl-phenyl)acetamide,
NCGC00185741-01,
2-[2-amino-3-(benzoyl)phenyl]acetamide,
AK323236,
DSSTox_CID_28564,
DSSTox_RID_82836,
DSSTox_GSID_48638,
SMR002529588,
Nepafenac [USAN],
CAS-78281-72-8,
nepafenaco,
nepafenacum,
Nepafena,
Nepafenac [USAN:INN:BAN:JAN],
Nevanac (TN),
PubChem17348,
AC1Q4ZKX,
AC1L45MC,
CHEMBL1021,
SCHEMBL93835,
MLS003915618,
MLS004774140,
MLS006010644,
Nepafenac (JAN/USAN/INN),
GTPL7564,
DTXSID0048638,
Nepafenac, >=98% (HPLC),
QEFAQIPZVLVERP-UHFFFAOYSA-N,
2-Amino-3-benzoyl-phenylacetamide,
HMS3654P07,
ACT02914,
BCP21333,
EX-A1350,
KS-000011BS,
ZINC5162311,
Tox21_112985,
AN-606,
BDBM50228731,
CN0055,
s1255,
STL451069,
AKOS005146108,
Tox21_112985_1,
AC-6949,
API0003541,
CS-0899,
DB06802,
RL05033,
NCGC00185741-02,
2-(2-Amino-3-benzoyl-phenyl)-acetamide,
AS-19176,
BC677673,
HY-17357,
SC-20092,
AB0031799,
AB1008448,
LS-186492,
LS-187354,
TL8005351,
FT-0080494,
FT-0603701,
N0932,
SW219197-1,
X5012,
2-[2-amino-3-(phenylcarbonyl)phenyl]acetamide,
A26218,
D05143,
W-5364,
AB01274763-01,
AB01274763_02,
281N728,
SR-01000931908,
I14-1056,
J-507774,
SR-01000931908-2,
BRD-K04112579-001-02-1,
2-Amino-3-benzoylbenzeneacetamide / 2-(2-Amino-3-benzoylphenyl)acetamide,
Nepafenac D5,
D02IHW,
cc-379,
C15H14N2O2,
CID151075,
C15-H14-N2-O2,
ACN-046771,
CS-O-01967,
A2890,
A10636,
Nepafenac, 99%, a selective COX-2 inhibitor - 1G 1g,
1246814-53-8,